Overview
Our work broadly falls under two areas: community engagement and political advocacy. In the Fall 2019 semester, we are currently organizing additional talks, drafting an Op-Ed on AMR, and expanding our team to include new students and postdoctoral affiliates.
November 4th 2019, 4-6PM: Career / Policy Chat with Kevin Outterson
Harvard AMR, IDC, and GPIB hosted a policy / career chat with Dr. Kevin Outterson, executive director of CARB-X, a non-profit antibacterial R&D partnership, and co-director of the health law program at BU.
We heard from Dr. Outterson on CARB-X's unique approach to address the pressing challenges of AMR and then delved into a broader discussion on similarities and differences compared to climate change science / advocacy, the role of "low-tech" versus "high-tech" solutions, and better public engagement on AMR.
November 1st, 2018: Fall AMR Symposium
HAMR was awarded a Harvard Integrated Life Sciences grant to host an interdisciplinary symposium
on antimicrobial resistance. We heard fantastic talks from trainees and faculty working on areas
ranging from drug development to population-wide epidemiology. Thanks to all the speakers and attendees
for a successful event!
February 7th, 2018: Inaugural Event
HAMR hosted Dr. Michael Gilmore, Principal Investigator of the Harvard-wide Program
on Antibiotic Resistance, for our inaugural event. Dr. Gilmore spoke about the fascinating
evolutionary history of drug-resistant Enterococci, which can cause devastating opportunistic
hospital-associated infections.